SUNNYVALE, Calif.--(BUSINESS WIRE)-- Covidien (NYS: COV) , a leading global provider of healthcare products, announced the expansion of its portfolio of radiofrequency ablation (RFA) catheters with ...

Leading health care products maker Covidien (NYSE:COV - News) is buying California-based privately held BARRX Medical in a bid to bolster its presence in gastrointestinal diseases therapy space. The ...

Acquisition to expand presence in GI treatments BARRX a leader in treating Barrett's esophagus Deal seen closing Jan. 31 Nov 21 (Reuters) - Healthcare products and medical device maker Covidien Plc ...

Health care major Covidien (NYSE:COV - News) has completed its takeover of California-based privately held BARRX Medical for roughly $325 million. The Ireland-based company forged a definitive deal to ...

Covidien has finalized a deal to acquire Barrx Medical for $325 million in cash, according to a Wall Street Journal report. The purchase brings Covidien into the gastroenterology field. Barrx will be ...

BARRX Medical Inc., a leader in developing minimally invasive medical devices used in conjunction with endoscopy to remove precancerous tissue from the gastrointestinal tract, announces today that ...

DUBLIN--(BUSINESS WIRE)--Covidien (NYSE: COV), a leading global provider of healthcare products and a world leader in advanced energy-based devices, today announced a definitive agreement to acquire ...

Covidien Introduces New Barrx™ RF Ablation Catheter for Treating Barrett's Esophagus Barrx™ Channel RFA Endoscopic Catheter eliminates need for multiple endoscope introductions; also offers enhanced ...